gogo logo
  • Монгол
  • Yolo
  • Maamuu
  • Politics
  • Economy
  • Society
  • Life
  • Interview
  • Culture
  • TRAVEL
  • Ulaanbaatar
  • Media OutReach
Helpful
Interview
  • - Interview
Interesting
Other
Монгол
Maamuu
Yolo
Main menu
Politics
Economy
Society
Life
Interview
Culture
TRAVEL
Ulaanbaatar
Media OutReach
Helpful
Interview
Interview
Interesting
Other menu
Монгол
Maamuu
Yolo
Contact us
Editorial ethics
Home
Search
Menu
  Facebook   Twitter
  Menu
Home
/ Society
Society

The Minister of Health and Sports G.Shiilegdamba pays working visit to U.S.

  Facebook   Tweet
 
  Facebook  Tweet
 

"Healthy Liver" program is being implemented by the Ministry of Health and Sports in cooperation with "Onom" foundation.

In scope of this program, the Minister of Health and Sports, G.Shiilegdamba paid working visit to San Francisco and Washington D.C. on March 2-8, 2015 to expand international cooperation with ofiicials.

They held meeting with representatives of Abbott Laboratories, which is the wolrd's leading American pharmaceuticals and health care products company, to discuss on decreasing the expensive cost of diagnosis to affordable cost on March 04. In Mongolia, diagnosis of hepatitis B, C is ranging at MNT130-150 thousand. However, the patient has to have tests for several times after and before treatment.

In result of the meeting, "Harvoni", which is indicated for the treatment of chronic hepatitis C, is to be used for treatment and is to be registered in Mongolian drug registration.

Moreover, they met with representatives of Stanford University and they made negotiations on exchanging Mongolian doctors and scientists for experience sharing sessions.

"Healthy Liver" program is being implemented by the Ministry of Health and Sports in cooperation with "Onom" foundation.

In scope of this program, the Minister of Health and Sports, G.Shiilegdamba paid working visit to San Francisco and Washington D.C. on March 2-8, 2015 to expand international cooperation with ofiicials.

They held meeting with representatives of Abbott Laboratories, which is the wolrd's leading American pharmaceuticals and health care products company, to discuss on decreasing the expensive cost of diagnosis to affordable cost on March 04. In Mongolia, diagnosis of hepatitis B, C is ranging at MNT130-150 thousand. However, the patient has to have tests for several times after and before treatment.

In result of the meeting, "Harvoni", which is indicated for the treatment of chronic hepatitis C, is to be used for treatment and is to be registered in Mongolian drug registration.

Moreover, they met with representatives of Stanford University and they made negotiations on exchanging Mongolian doctors and scientists for experience sharing sessions.

  Facebook   Tweet
Category
Society
Published
2015-03-09


gogo logo
Contact us Editorial ethics

© 2007 - 2025 Mongol Content LLC